TY - JOUR AU - Gómez-Arias, Pedro Jesús AU - Gómez-García, Francisco AU - Hernández-Parada, Jorge AU - Montilla-López, Ana María AU - Ruano, Juan AU - Parra-Peralbo, Esmeralda PY - 2021 DO - 10.1007/s13555-021-00517-9 SN - 2193-8210 UR - http://hdl.handle.net/10668/4440 T2 - Dermatology and Therapy AB - ImportanceType I interferon (IFN)-mediated monogenic autoinflammatory disorders (interferonopathies) are childhood-onset rare multisystemic diseases with limited treatment options. The Janus kinase (JAK) inhibitors are promising potential therapeutic... LA - en PB - Springer Nature KW - CANDLE KW - SAVI KW - Familial chilblain lupus KW - JAK inhibitors KW - Autoinflammatory diseases KW - Interferon pathway KW - Ruxolitinib KW - Tofacitinib KW - Baricitinib KW - Viremia KW - Type I interferon KW - Interferonopathies KW - Inhibidores de las cinasas Janus KW - Enfermedades autoinflamatorias hereditarias KW - Interferón de tipo I KW - Bases de datos bibliográficas KW - Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans KW - Medical Subject Headings::Persons::Persons::Age Groups::Child KW - Medical Subject Headings::Information Science::Information Science::Information Storage and Retrieval::Databases as Topic::Databases, Bibliographic::PubMed::MEDLINE KW - Medical Subject Headings::Diseases::Virus Diseases::Viremia KW - Medical Subject Headings::Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Peptides::Intercellular Signaling Peptides and Proteins::Cytokines::Interferons::Interferon Type I KW - Medical Subject Headings::Chemicals and Drugs::Enzymes and Coenzymes::Enzymes::Transferases::Phosphotransferases::Phosphotransferases (Alcohol Group Acceptor)::Protein Kinases::Protein-Tyrosine Kinases::Janus Kinases KW - Medical Subject Headings::Diseases::Respiratory Tract Diseases::Respiratory Tract Infections KW - Medical Subject Headings::Information Science::Information Science::Communications Media::Publications::Bibliography as Topic::Bibliometrics TI - Efficacy and Safety of Janus Kinase Inhibitors in Type I Interferon-Mediated Monogenic Autoinflammatory Disorders: A Scoping Review TY - review article ER -